HempFusion Wellness Inc. Announces 2021 AGM Voting Results
May 17 2021 - 9:15AM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a
leading health and wellness consumer packaged goods Company, is
pleased to announce the voting results from its Annual General
Meeting of holders (“Shareholders”) of common shares
(“Common Shares”) the Company held Friday, May 14,
2021 in a virtual-only format (the “Meeting”).
All the matters put forward before Shareholders for
consideration and approval as set out in the Company’s management
information circular dated April 7, 2021 (the “Circular”)
were approved by the requisite majority of votes cast at the
Meeting. In particular, Shareholders approved the election of all
director nominees as follows:
Votes in Favour
Votes Withheld
% of Votes Cast in Favour
(rounded)
Jason Mitchell
21,035,729
4,869,944
81.20%
Ian Dequeiroz
21,031,598
4,874,075
81.19%
G. Scott Greenburg
21,036,498
4,869,175
81.20%
Nick Grafton
20,969,966
4,935,707
80.95%
Merrick Andlinger
25,901,338
4,335
99.98%
David Doherty
25,577,442
328,231
98.73%
Gordon Fox
25,835,206
70,467
99.73%
Desmond Balakrishnan
20,710,133
5,195,540
79.94%
Shareholders also approved the appointment of MNP LLP as auditor
of the Company for the ensuing year.
The total number of Common Shares represented by Shareholders in
person or by proxy at the Meeting was 26,247,492 Common Shares,
representing 22.37% of the total issued and outstanding Common
Shares. Detailed voting results are available under the Company’s
profile on SEDAR at www.sedar.com.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accept
responsibility for the adequacy or accuracy of this
release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210517005497/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2023 to Apr 2024